Laboratory of Probiogenomics, Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy.
APC Microbiome Institute and School of Microbiology, National University of Ireland, Cork, Ireland.
Microbiol Mol Biol Rev. 2017 Nov 8;81(4). doi: 10.1128/MMBR.00036-17. Print 2017 Dec.
The human gut microbiota is engaged in multiple interactions affecting host health during the host's entire life span. Microbes colonize the neonatal gut immediately following birth. The establishment and interactive development of this early gut microbiota are believed to be (at least partially) driven and modulated by specific compounds present in human milk. It has been shown that certain genomes of infant gut commensals, in particular those of bifidobacterial species, are genetically adapted to utilize specific glycans of this human secretory fluid, thus representing a very intriguing example of host-microbe coevolution, where both partners are believed to benefit. In recent years, various metagenomic studies have tried to dissect the composition and functionality of the infant gut microbiome and to explore the distribution across the different ecological niches of the infant gut biogeography of the corresponding microbial consortia, including those corresponding to bacteria and viruses, in healthy and ill subjects. Such analyses have linked certain features of the microbiota/microbiome, such as reduced diversity or aberrant composition, to intestinal illnesses in infants or disease states that are manifested at later stages of life, including asthma, inflammatory bowel disease, and metabolic disorders. Thus, a growing number of studies have reported on how the early human gut microbiota composition/development may affect risk factors related to adult health conditions. This concept has fueled the development of strategies to shape the infant microbiota composition based on various functional food products. In this review, we describe the infant microbiota, the mechanisms that drive its establishment and composition, and how microbial consortia may be molded by natural or artificial interventions. Finally, we discuss the relevance of key microbial players of the infant gut microbiota, in particular bifidobacteria, with respect to their role in health and disease.
人类肠道微生物群在宿主的整个生命周期中参与多种影响宿主健康的相互作用。微生物在出生后立即定植于新生儿肠道。人们认为,这种早期肠道微生物群的建立和相互发展(至少部分)是由人乳中存在的特定化合物驱动和调节的。已经表明,婴儿肠道共生菌的某些基因组,特别是双歧杆菌属物种的基因组,在遗传上适应于利用这种人分泌液中的特定聚糖,因此代表了宿主-微生物共同进化的一个非常有趣的例子,在这种共同进化中,两个伙伴都被认为是受益的。近年来,各种宏基因组研究试图剖析婴儿肠道微生物组的组成和功能,并探索其在不同生态位中的分布,包括在健康和患病个体中与细菌和病毒相对应的微生物群落的婴儿肠道生物地理学。这些分析将微生物组的某些特征(如多样性降低或组成异常)与婴儿肠道疾病或在生命后期表现出的疾病状态(包括哮喘、炎症性肠病和代谢紊乱)联系起来。因此,越来越多的研究报告了婴儿肠道微生物群的早期组成/发育如何影响与成人健康状况相关的风险因素。这一概念推动了基于各种功能性食品产品来塑造婴儿微生物群组成的策略的发展。在这篇综述中,我们描述了婴儿微生物群、驱动其建立和组成的机制,以及微生物群落如何通过自然或人工干预来塑造。最后,我们讨论了婴儿肠道微生物群的关键微生物参与者,特别是双歧杆菌,在健康和疾病中的作用的相关性。